Patrys Beheer

Beheer criteriumcontroles 4/4

De CEO Patrys is James Campbell, benoemd in Apr2015, heeft een ambtstermijn van 9.58 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 487.07K, bestaande uit 76.5% salaris en 23.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.92% van de aandelen van het bedrijf, ter waarde A$ 84.98K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.1 jaar en 6.5 jaar.

Belangrijke informatie

James Campbell

Algemeen directeur

AU$487.1k

Totale compensatie

Percentage CEO-salaris	76.5%
Dienstverband CEO	9.6yrs
Eigendom CEO	0.9%
Management gemiddelde ambtstermijn	3.1yrs
Gemiddelde ambtstermijn bestuur	6.5yrs

Recente managementupdates

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Recent updates

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Mar 24

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

Analyse CEO-vergoeding

Hoe is James Campbell's beloning veranderd ten opzichte van Patrys's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$487k	AU$373k	-AU$4m
Mar 31 2024	n/a	n/a	-AU$4m
Dec 31 2023	n/a	n/a	-AU$5m
Sep 30 2023	n/a	n/a	-AU$6m
Jun 30 2023	AU$735k	AU$358k	-AU$7m
Mar 31 2023	n/a	n/a	-AU$7m
Dec 31 2022	n/a	n/a	-AU$6m
Sep 30 2022	n/a	n/a	-AU$6m
Jun 30 2022	AU$718k	AU$327k	-AU$7m
Mar 31 2022	n/a	n/a	-AU$7m
Dec 31 2021	n/a	n/a	-AU$7m
Sep 30 2021	n/a	n/a	-AU$5m
Jun 30 2021	AU$601k	AU$325k	-AU$4m
Mar 31 2021	n/a	n/a	-AU$4m
Dec 31 2020	n/a	n/a	-AU$3m
Sep 30 2020	n/a	n/a	-AU$3m
Jun 30 2020	AU$434k	AU$318k	-AU$3m
Mar 31 2020	n/a	n/a	-AU$3m
Dec 31 2019	n/a	n/a	-AU$3m
Sep 30 2019	n/a	n/a	-AU$2m
Jun 30 2019	AU$504k	AU$305k	-AU$411k
Mar 31 2019	n/a	n/a	-AU$511k
Dec 31 2018	n/a	n/a	-AU$611k
Sep 30 2018	n/a	n/a	-AU$2m
Jun 30 2018	AU$399k	AU$280k	-AU$2m

Compensatie versus markt: De totale vergoeding ($USD 316.69K ) James } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 298.50K ).

Compensatie versus inkomsten: De vergoeding van James is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

James Campbell

9.6yrs

Tenure

AU$487,074

Compensatie

Dr. James A. Campbell, BSc(Hons), PhD, MBA, GAICD, serves as Chief Executive Officer and Managing Director for Patrys Limited since April 13, 2015. Dr. Campbell serves as Principal of Gemini Biotechnology....

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
James Campbell	MD, CEO & Executive Director	9.6yrs	AU$487.07k	0.92% A$ 85.0k
Rebecca Tunstall	Vice President of Corporate Development	2.5yrs	geen gegevens	geen gegevens
Stefan Ross	Company Secretary	3.1yrs	AU$12.67k	geen gegevens
Valentina Dubljevic	Vice President of Research & Development	no data	geen gegevens	geen gegevens

3.1yrs

Gemiddelde duur

Ervaren management: Het managementteam van PAB wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
James Campbell	MD, CEO & Executive Director	10yrs	AU$487.07k	0.92% A$ 85.0k
Pamela M. Klein	Non-Executive Director	5.1yrs	AU$91.43k	0.012% A$ 1.1k
Peter Ordentlich	Member of Scientific Advisory Board	4.5yrs	geen gegevens	geen gegevens
Michael Stork	Non- Executive Deputy Chairman	17.8yrs	geen gegevens	4.8% A$ 444.5k
Allen Ebens	Member of Scientific Advisory Board	7.9yrs	geen gegevens	geen gegevens
Charmaine Gittleson	Non-Executive Chairman of the Board	2yrs	AU$106.94k	geen gegevens

6.5yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van PAB wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).

Patrys Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Patrys Limited, Annual General Meeting, Nov 22, 2024

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Patrys Limited, Annual General Meeting, Nov 15, 2023

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Recent updates

Patrys Limited, Annual General Meeting, Nov 22, 2024

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2023)

New major risk - Market cap size

New major risk - Share price stability

New major risk - Market cap size

New major risk - Market cap size

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2022)

Patrys Limited, Annual General Meeting, Nov 15, 2023

New minor risk - Financial data availability

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2021)

Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification Tests

Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1

Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

No independent directors

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

MD, CEO & Executive Director exercised options to buy AU$360k worth of stock.

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2020)

Patrys Limited Provides This Interim Update on Its PAT-DX1 Clinical Trial Program

Patrys Limited Announces Full Size Deoxymab PAT-DX3 Able to Cross the Blood Brain Barrier

Patrys Limited Announces the Publication of New Preclinical Data for Its Deoxymab Antibody PAT-DX1

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

Patrys Limited Successfully Establishes PAT-DX1 Stable Cell Line

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Patrys Limited Adds Full Human Antibody to Deoxymab Portfolio

Earnings released

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur